Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA appointment

This article was originally published in The Tan Sheet

Executive Summary

John Gardiner, MD/PhD, is joining the agency as director, Division of Compliance Risk Management & Surveillance in the Office of Compliance, FDA announces Feb. 7. He retired from the military as program manager for population medicine in the Office of the Secretary of Defense in 2004. Gardiner will be responsible for "helping DCRMS accomplish its mission of implementing programs and projects to identify, assess and prioritize legal violations based upon their public health significance." Gardiner replaces Kathy Miracco, who served as acting division director for two years...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel